Advanced Search
Now showing items 1-10 of 15
Treatment of systemic and refractory adult-onset still's disease with Tofacitinib. efficacy of JAK/STAT Pathway inhibition
(Lippincott Williams & Wilkins, 2020)
Aberrant MUC1 accumulation in salivary glands of Sjogren's syndrome patients is reversed by TUDCA in vitro
(Oxford University Press, 2020)